Table of Contents Introduction Non Alcoholic Fatty Liver Disease (NAFLD) - Overview Non Alcoholic Fatty Liver Disease (NAFLD) - Therapeutics Development Non Alcoholic Fatty Liver Disease (NAFLD) - Therapeutics Assessment Non Alcoholic Fatty Liver Disease (NAFLD) - Companies Involved in Therapeutics Development Non Alcoholic Fatty Liver Disease (NAFLD) - Drug Profiles Non Alcoholic Fatty Liver Disease (NAFLD) - Dormant Projects Non Alcoholic Fatty Liver Disease (NAFLD) - Discontinued Products Non Alcoholic Fatty Liver Disease (NAFLD) - Product Development Milestones Appendix

List of Tables Number of Products under Development for Non Alcoholic Fatty Liver Disease (NAFLD), H1 2019 Number of Products under Development by Companies, H1 2019 Number of Products under Development by Universities/Institutes, H1 2019 Products under Development by Companies, H1 2019 Products under Development by Universities/Institutes, H1 2019 Number of Products by Stage and Target, H1 2019 Number of Products by Stage and Mechanism of Action, H1 2019 Number of Products by Stage and Route of Administration, H1 2019 Number of Products by Stage and Molecule Type, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Akcea Therapeutics Inc, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Ardelyx Inc, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by AstraZeneca Plc, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Betagenon AB, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by BioElectron Technology Corp, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Bird Rock Bio Inc, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Boehringer Ingelheim GmbH, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Cadila Healthcare Ltd, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Can-Fite BioPharma Ltd, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Carmot Therapeutics Inc, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Cerenis Therapeutics Holding SA, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Corcept Therapeutics Inc, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Dr. Falk Pharma GmbH, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by DURECT Corp, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Eli Lilly and Co, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Enanta Pharmaceuticals Inc, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Eternygen GmbH, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Evgen Pharma Plc, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by F. Hoffmann-La Roche Ltd, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Galmed Pharmaceuticals Ltd, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Gemphire Therapeutics Inc, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by GemVax & KAEL Co Ltd, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Gilead Sciences Inc, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Guangdong Zhongsheng Pharmaceutical Co Ltd, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Hanmi Pharmaceuticals Co Ltd, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by HemoShear Therapeutics, LLC, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Huons Global Co Ltd, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Immuron Ltd, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Inventiva, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Ionis Pharmaceuticals Inc, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Kinomedica Pty Ltd, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Kowa Co Ltd, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Kyorin Pharmaceutical Co Ltd, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by MallInckrodt Plc, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Metacrine Inc, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Mina Therapeutics Ltd, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by Novartis AG, H1 2019 Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline by NuSirt Biopharma Inc, H1 2019List of Figures Number of Products under Development for Non Alcoholic Fatty Liver Disease (NAFLD), H1 2019 Number of Products under Development by Companies, H1 2019 Number of Products by Top 10 Targets, H1 2019 Number of Products by Stage and Top 10 Targets, H1 2019 Number of Products by Top 10 Mechanism of Actions, H1 2019 Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019 Number of Products by Routes of Administration, H1 2019 Number of Products by Stage and Routes of Administration, H1 2019 Number of Products by Top 10 Molecule Types, H1 2019 Number of Products by Stage and Top 10 Molecule Types, H1 2019

Akcea Therapeutics Inc Ardelyx Inc AstraZeneca Plc Betagenon AB BioElectron Technology Corp Bird Rock Bio Inc Boehringer Ingelheim GmbH Cadila Healthcare Ltd Can-Fite BioPharma Ltd Carmot Therapeutics Inc Cerenis Therapeutics Holding SA Corcept Therapeutics Inc Dr. Falk Pharma GmbH DURECT Corp Eli Lilly and Co Enanta Pharmaceuticals Inc Eternygen GmbH Evgen Pharma Plc F. Hoffmann-La Roche Ltd Galmed Pharmaceuticals Ltd Gemphire Therapeutics Inc GemVax & KAEL Co Ltd Gilead Sciences Inc Guangdong Zhongsheng Pharmaceutical Co Ltd Hanmi Pharmaceuticals Co Ltd HemoShear Therapeutics, LLC Huons Global Co Ltd Immuron Ltd Inventiva Ionis Pharmaceuticals Inc Kinomedica Pty Ltd Kowa Co Ltd Kyorin Pharmaceutical Co Ltd MallInckrodt Plc Metacrine Inc Mina Therapeutics Ltd Novartis AG NuSirt Biopharma Inc Pfizer Inc Phenex Pharmaceuticals AG Renova Therapeutics Inc Ritter Pharmaceuticals Inc Sancilio & Company Inc Shenzhen HighTide Biopharmaceutical Ltd T3D Therapeutics Inc TaiwanJ Pharmaceuticals Co Ltd TCM Biotech International Corp Theratechnologies Inc Tiziana Life Sciences Plc Viking Therapeutics Inc